Labcritics Alerts / Sign-up to get alerts on discounts, new products, apps, protocols and breakthroughs in tools that help researchers succeed.
Reachout to Researchers with Our Extensive Marketing Network
Modern scientific marketing partner built for life science brands
A research group from Tel Aviv University has found a new way to re-sensitize bacteria to antibiotics. In their PNAS publication they describe how they used phages to introduce the genome editing system CRISPR-Cas to revert antibiotic resistance and eliminate horizontal transfer of resistance between strains. This system could reduce the prevalence of antibiotic-resistant bacteria in hospital surfaces and medical personnel.
Bacteria are increasingly resistant to chemicals that were found out or designed to kill them. Other ways of attacking infections have been explored since, like using bacteriophages, viruses that infect and replicate within bacteria, usually lysing their host to release new virions. However, this strategy can be failed if bacteria develop a resistance to phages. Ido Yosef and coworkers resolved to use temperate bacteriophages to deliver the genome editing tool CRISPR-Cas designed to specifically target β-lactamase, the gene that helps bacteria become resistant to Beta-lactam antibiotics like penicillin. Beta-lactams are typically used to treat a broad spectrum of Gram-positive and Gram-negative bacteria. The researchers proved that targeted E. coli bacteria became sensitive to Beta-lactam antibiotics, which meant they had lost their resistance. Crucially, their CRISPR-Cas design also confers protection from lytic phages, so that these phages will kill only antibiotic-resistant bacteria and respect the sensitized bacteria.
Specificity of interaction can also be achieved by proper selection of phage class. Attacks can be directed to a specific bacterium, while keeping non-damaging bacteria safe. Authors propose the use of this system in hospital surfaces and hand sanitizers.
We use cookies to provide you with the best possible experience. They also allow us to analyze user behavior in order to constantly improve the website for you. Privacy Policy
Privacy Preference
Strictly NecessaryAlways on
Performance
Functionality
Targeting or Advertising
Strictly Necessary
These cookies are necessary for the site to work and cannot be switched off. They are set in response to things you do — signing in, submitting a form, or recording the privacy choices on this panel. They also cover the spam protection on our forms. You can block them in your browser, but parts of the site will stop working.
Performance
Analytics that tell us which pages are read and how people arrive, so we know what to write more of. We use Google Analytics for this. Decline and it still counts the visit, but without cookies and without anything that could identify you.
Functionality
Remembers preferences so the site behaves consistently between visits — things like dismissed notices and choices you have already made. Declining loses those conveniences; nothing else breaks.
Targeting or Advertising
Used to measure sponsorships and show relevant promotions. Labcritics does not sell your data, and sponsors never receive it. Declining means promotions are untargeted — you will see the same number of them.